Clinical Trials Logo

Clinical Trial Summary

This is a 36 week open-label extension of the canakinumab pre-filled syringe study for safety and tolerability in patients who have frequent flares of acute gouty arthritis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01431638
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 3
Start date August 25, 2011
Completion date May 9, 2013

See also
  Status Clinical Trial Phase
Withdrawn NCT01593527 - Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease Phase 3
Recruiting NCT02545777 - The Clinical Study on Treating Acute Gouty Arthritis Using Both Internal and External Therapy of Tonifying Spleen and Descending Turbid Phase 2
Completed NCT01356602 - Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients Phase 3
Completed NCT00170781 - Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout Phase 4
Not yet recruiting NCT06273813 - Treatment of Topical Ketorolac Gel in Acute Gouty Flare Phase 1
Completed NCT03002974 - A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis Phase 2